💉 Sudan Launches Malaria Vaccination Campaign

by Dr Natalie Singh - Health Editor
0 comments

Sudan Launches Malaria Vaccine Program, Offering Hope to Vulnerable Children

In a significant step towards combating malaria, Sudan has launched an extensive vaccination program targeting young children. The program aims to protect vulnerable populations from this deadly disease, which continues to pose a serious threat to public health in the country.

First Doses Arrive, Reaching Thousands of Children

The first delivery of 186,000 malaria vaccine doses arrived in October, marking the official start of the program. These doses will reach over 148,000 children under one year old in 15 areas across the Gedaref and Blue Nile states. This initial rollout is a crucial first step in a larger plan to expand access to the vaccine.

Six-month-old Adan Mohammed is the first to receive the vaccine.

Sudan’s Minister of Health, Dr. Akram Ali, expressed optimism about the program’s potential impact, stating, “This vaccine is a vital tool in our fight against malaria. We are committed to ensuring that all eligible children receive the protection they need.”

Expanding Access: Reaching More Children in the Coming Years

The vaccination program is set for significant expansion in the coming years. During 2025 and 2026, the vaccine is planned to be introduced in 129 areas across Sudan, reaching a wider population of vulnerable children.

Malaria’s Deadly Toll: A Major Public Health Concern in Sudan

Malaria remains a major public health concern in Sudan. During 2023, over 3.4 million malaria cases were reported, with an estimated 7,900 lives lost. These figures likely underestimate the true impact of the disease due to ongoing conflict disrupting healthcare systems and data collection.

The World Health Organization (WHO) estimates that malaria kills nearly half a million children under five years old annually in Africa. The new vaccine offers a crucial opportunity to reduce this devastating toll.

Vaccine Administration and Importance of Continued Prevention Efforts

The malaria vaccine is administered to children between 5 and 12 months of age. For optimal protection, children require a total of four doses. While the vaccine is a significant advancement, it is crucial to continue other preventive measures, such as using insecticide-treated mosquito nets and promoting early diagnosis and treatment.

Challenges to Vaccination Coverage: Conflict and Disruption

The ongoing conflict in Sudan has significantly impacted vaccination coverage. National coverage has dropped from 85 percent before the war to approximately 50 percent. In active conflict zones, vaccination coverage is as low as 30 percent. This low coverage, coupled with frequent disease outbreaks, puts millions of unvaccinated children at risk.

The launch of the malaria vaccination program is a crucial step towards protecting Sudan’s children from this deadly disease. Continued support and investment are essential to ensure the program’s success and expand access to life-saving vaccines for all children in need.

Learn more about the global fight against malaria and how you can help: https://www.gavi.org/news/media-room/sudan-rolls-out-first-malaria-vaccines?ref=warpnews.org

Related Posts

Leave a Comment